Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

59.74
+0.98001.67%
Post-market: 60.650.9130+1.53%19:58 EDT
Volume:2.72M
Turnover:163.43M
Market Cap:9.93B
PE:-17.17
High:60.92
Open:59.64
Low:59.06
Close:58.76
52wk High:86.74
52wk Low:41.71
Shares:166.18M
Float Shares:161.92M
Volume Ratio:1.15
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:22.58
PE(LYR):-25.09

Loading ...

Ionis Pharmaceuticals, Inc. : Bmo Initiates Coverage with Market Perform Rating; Price Target $60

THOMSON REUTERS
·
Aug 19

BMO Capital starts Ionis at Market Perform pending better visibility

TIPRANKS
·
Aug 19

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)

TIPRANKS
·
Aug 15

Ionis Pharmaceuticals (IONS) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Ionis Pharmaceuticals Earnings Call Highlights Pipeline And Growth

TIPRANKS
·
Aug 12

J.P. Morgan Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Aug 10

Novartis Might Struggle to Clear Bar in Cholesterol Drug Trial

Dow Jones
·
Aug 10

Ionis Pharmaceuticals (IONS) Receives a Hold from Stifel Nicolaus

TIPRANKS
·
Aug 03

Ionis Director Michael R. Hayden Reports Acquisition of 20,000 Common Shares Worth $1,059,000

Reuters
·
Aug 01

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings
·
Jul 31

Ionis Pharmaceuticals: Strong Commercial Momentum and Late‑Stage Pipeline Catalysts Drive Buy Rating

TIPRANKS
·
Jul 31

Ionis Pharmaceuticals is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jul 30

Alnylam Q2 Revenue Rises 67% on Increased Demand for Amvuttra

Reuters
·
Jul 30

RBC Capital Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 30

Ionis Pharmaceuticals price target lowered to $115 from $125 at H.C. Wainwright

TIPRANKS
·
Jul 30

Ionis Pharmaceuticals price target raised to $69 from $66 at Goldman Sachs

TIPRANKS
·
Jul 30

Viking Therapeutics Reports Q2 Milder-than-expected Net Loss as Obesity Trials Advance

Reuters
·
Jul 30

Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio

Benzinga Earnings
·
Jul 30

Ionis Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Analysts Are Bullish on Top Healthcare Stocks: Option Care Health (OPCH), Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 29